Process improvement for government drug procurement in India
Harleen Kaur (),
Ajay Shah and
Siddhartha Srivastava ()
Additional contact information
Harleen Kaur: Independent Researcher'
Siddhartha Srivastava: NIPFP
No 18, Working Papers from xKDR
In India, drug quality is an important problem. Government agencies are an important buyer of drugs, and also face significant problems with drug quality. In this paper, we examine the mechanisms used for drug purchase by four Indian states - Rajasthan, Punjab, Bihar and Gujarat. We establish a taxonomy of 13 design elements that define the drug procurement process. We engage in deductive reasoning about the design elements that appear to be useful and those that are less so. This work would help policy makers placed in an Indian public sector context in devising better procedures for drug purchase.
JEL-codes: H83 I11 I18 (search for similar items in EconPapers)
Pages: 19 pages
New Economics Papers: this item is included in nep-law
References: View complete reference list from CitEc
Citations: Track citations by RSS feed
Downloads: (external link)
https://papers.xkdr.org/papers/KSS2021_improving_india_drugs_procurement.pdf First version, 2022 (application/pdf)
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
Persistent link: https://EconPapers.repec.org/RePEc:anf:wpaper:18
Access Statistics for this paper
More papers in Working Papers from xKDR
Bibliographic data for series maintained by Ami Dagli ().